| abstract |
The present invention is directed to yolk sac stem cells. In particular, it relates to the characterization, culturing, and uses of yolk sac stem cells for hematopoietic reconstitution and therapy. Yolk sac stem cells isolated from the early embryonic yolk sac prior to blood island formation exhibit a homogeneous morphology and primitive cell surface phenotype without the expression of mature leukocyte markers and major histocompatibility complex encoded antigens. The cells can be cultured and expanded long-term without alteration of their pluripotency. Therefore, yolk sac stem cells may have a wide range of applications including but not limited to the reconstitution of a destroyed or deficient human hematopoietic system, and the construction of large and small animal models for the production of human blood cells, human antibodies, and testing of human diseases, immune function, vaccines, drugs and immunotherapy. |